DRUG DISCOVERY 2024: CONNECTING MINDS, TRANSFORMING SCIENCE, EMPOWERING COMMUNITY
Event overview
Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling. This year’s Scientific Content Partners are the Cell & Gene Therapy Catapult, the Royal Society of Chemistry, SBi2 and SLAS, all of whom are providing science tracks prepared by their community members. And in the middle of all this science there is the exhibition hall, which is a great opportunity to meet over two hundred drug discovery suppliers and to learn about all the latest products and services you can use in your research.
Whether you’re involved in early drug discovery research or translating your promising therapy to the clinic, you’ll be sure to discover something that can help you at this year’s event.
ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and with a prayer room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events.
Drug Discovery 2024 Conference Directors:
Katie Chapman
Tessellate Bio
Andy Merritt
Life Arc
Alex Alderton
AstraZeneca
Laura Eghobamien
Black Medical Scientific Network
ADDITIONAL ACTIVITIES AVAILABLE AT DRUG DISCOVERY 2024
Find out more…
At Drug Discovery 2024 we are thrilled to continue our commitment to fostering a passion for STEM among the next generation. We will be welcoming local students to ExCeL who will have the opportunity to explore the world of science with hands-on experiments, captivating demos, using cutting edge equipment and take part in an engaging Q&A session with our Early Career Professional team. We believe that inspiring young minds is key to building a brighter, more innovative future. together we are nurturing the scientists of tomorrow.
This inspiring space will be focussing on two key themes – Sustainability in Drug Discovery on Day 1 and and Robotics, Automation and AI: Driving Innovations and Key Applications in Drug Discovery on Day 2! Hosted by industry experts you can be sure these sessions will ignite your passion and get you thinking!
We recognise the vital role that young companies play in driving innovation, so to support and amplify their contributions we’re delighted to introduce the ELRIG Breakthrough Zone. If you might be interested in featuring in this space please fill out our application form and tell us about your innovation in 300 words by 31 August. Select Breakthrough Zone from the drop down menu to find out more! We’re also offering our Breakthrough Zone participants a chance to win a presentation as part of the main programme at Drug Discovery! So grab the opportunity to exhibit at Europe’s biggest Drug Discovery event now!
Find the ELRIG team centrally located in hall N2. This space will include our media lounge, speaker ready table, Sales team and a place to meet. Pop by and say hello, check out our events planned for 2025! Secure your spot and get ahead!
Celebrating the innovation, scientific successes and personal achievements of our community is extremely important to us. We are proud to be able to recognise talent and valuable research through the giving of awards at Drug Discovery 2024. Awards categories are as follows: ELRIG’s ECP Impact Award, ELRIG’s Best ECP Poster. Head to the Awards page in the drop down for more info.
Join us for a networking session like no other…aimed at early career professionals – you can meet with industry experts, forge new connections, listen to their tips to the top and understand strategies to help your career. Just turn up and join this speedy, buzzy networking event, you’ll be glad you did! Tuesday 2nd October 17:00-18:30 at the ELRIG Hub.
Posters
Discover 260+ posters and innovative research from across the drug discovery community, aligned to our track themes. Hear from our Flash Poster Presenters and find out who has won the coveted Early Career Professional Poster Award!
Career Zone
Meet future employers at the Career Zone.
Find out what roles are available in organisations like AstraZeneca, GSK and more! Build connections with recruiters, like SRG, and learn how you can contribute to scientific advancements in drug discovery.
Also, grab your chance to get a free professional headshot for your next career move, with our event photographer.
Learning Zone
Drop in to our Learning Zone each morning for our Early Career Professional ‘Meet & Greet’ session 8-9am, meet fellow ECP members and other delegates before all the science kicks off! Also in the Learning Zone, hear from some fantastic speakers about recruiting early talent and the importance of ‘Building Bridges for Inclusion’.
Do not miss the networking event of the year… Join us in the Learning Zone from 5:30-6:30pm for ‘Network Like a Boss’ speed network with some incredible ‘bosses’ you wont be disappointed in this fun, fast paced end to the day. Refreshments provided.
Day 1 – Wed 2 Oct
Auditorium 1
Advances in Assay Development and Screening – supported by SLAS
TRACK CHAIRS: Saman Honarnejad (Pivot Park) and Amy Brook (Charles River)
Abstract
Recent shifts towards less druggable target classes, novel small-molecule modalities, exploitation of artificial intelligence and machine learning methods, and other enabling technologies has fundamentally changed the types of bioassays and screening approaches required to support various lead generation strategies. In this track you will hear about the latest innovations aiding identification of high quality biologically active molecules, including advances across biology, chemistry, automation, readout technologies, data science, and how these integrate into hit discovery workflows.
Auditorium 2
Translating ideas into Therapies
TRACK CHAIRS: Hitesh Sanganee (AstraZeneca) and Kerstin Papenfuss (Deep Science Ventures)
Abstract
The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex, so this session will outline some of the most exciting technology advancements and approaches that have led to new therapeutics to the clinic. The speakers will discuss what made the crucial difference but also the challenges they faced along the way. This will include successes in; AI, bifunctionals, microbiome, repurposing, gene editing and more….
Auditorium 3
Therapeutic Discovery for Healthy Ageing
TRACK CHAIRS: Janet Brownlees (MSD) and Linda Partridge (UCL)
Abstract
The World Health Organization defines healthy or active ageing as ‘the process of developing and maintaining the functional ability that enables well-being in older age’. This can be a combination of healthy lifestyle as well as therapeutic intervention to promote healthy ageing in a disease context. The track will focus on therapeutic approaches across a range of age-related diseases including neurodegeneration, inflammation, ophthalmology and muscle function. Therapeutics can include small or large molecule or other genetic modalities such as ASOs. Although the focus will be on therapeutic and biomarker discovery, basic research on mechanisms of ageing will also be of great interest in this track.
Auditorium 4
Small molecules beyond Rule of 5 – Modalities, Developments and Learnings
TRACK CHAIRS: Jon Large (LifeArc) and Mark Frigerio (Bicycle Tx)
Abstract
The small molecule discovery field is continuing to reach into innovative and enabling new paradigms, both by employing an increasingly diverse arsenal of chemical modalities, and by exploiting technological advances and applications in established fields of study. Among key areas, small molecules which expand beyond Lipinski-type guidelines based on the Rule-of-5 (Ro5) are providing many new approaches to discovery and translational medicinal chemistry. Our expert speakers in this session will highlight the latest research strategies, innovations in molecular design, workflows and lessons learned in aspects of peptide and Protac chemistries and highlight future opportunities for these contemporary modalities in expanded property space.
#BRo5 #peptides #protacs #medchem
TECH THEATRE
Raising the Bar: Mainstreaming sustainability and ethical research practices in drug discovery
TRACK CHAIRS: Kelly Gray (AstraZeneca) and James Connelly (My Green Lab)
Abstract
The track focuses on highlighting the significance of sustainable practices and ethical research in drug discovery, exploring the benefits of aligning drug discovery with environmentally conscious and socially responsible principles. We will seek to address the challenges and opportunities associated with driving this paradigm shift, by highlighting the need for collaborative efforts and innovative approaches to drive meaningful change. Our speakers will explore the role of technology and interdisciplinary collaboration in promoting sustainable drug discovery practices, whilst acknowledging ethical considerations in research, including respect for human subjects, animal welfare, and fair access to treatments. Our intent is to advocate for mainstreaming sustainability and ethical research practices in drug discovery, in recognition of the potential impact in contributing to global health and environmental stewardship
BREAKTHROUGH ZONE
Breakthrough Zone Company Showcase
Track Chairs: Louise-Jane Affleck (Revvity) & Sarah Lupton (ELRIG)
Abstract
The Breakthrough Zone (BZ) welcomes innovative start-up life science companies, each developing cutting edge technologies and platforms to drive drug discovery. In this track BZ companies will showcase their ground-breaking science and impact areas in a quick-fire 3-slide, 5-minute presentation format. The goal of the session is to introduce attendees to the most exciting developments in the field and connect them to new users, collaborators and entrepreneurs.
Day 2 – Thurs 3 Oct
Auditorium 1
Impacts of Biomolecular Imaging and Informatics in Drug Discovery – supported by SBi2
TRACK CHAIRS: Richard Kasprowicz (GSK) and Ceri Wiggins (AZ)
Abstract
High content imaging platforms enable generation of rich data sources in ever more complex cell systems, which sophisticated AI/ML informatics approaches can interrogate to provide invaluable insights in drug discovery. The last decade has seen an expansion in the number of medium to high-throughput image-based screens driven by technological innovation in industry and academia, application to a wider variety of modalities, and combination with omics technologies including phenomics-based strategies that use imaging at their core. This session focusses on innovative approaches in high content imaging and analytics, highlighting the power of data from imaging technologies in driving drug candidate progression
Auditorium 2
Target Discovery and Disease Modelling
TRACK CHAIRS: Davide Gianni (AZ) and Rebecca Harris (Cancer Research Horizons)
Abstract
Drug attrition in clinical trials due to inaccurate preclinical target validation is a huge problem facing drug discovery. This suggests that often the ‘wrong’ target has been selected as the focus of the therapeutic program. The selection of the “right” target is one of the most important decisions in the drug discovery process, and while patient-focused multi-omics datasets are increasingly available, the lack of translatable disease models used to identify and validate such targets preclinically remains challenging.
This track will focus on innovative and ‘state of the art’ approaches taken by researchers to harness the growing resource of biomedical data sets, understand key disease driving mechanisms in relevant model systems and discover novel therapeutic opportunities for therapeutic intervention.
Auditorium 3
Innovation in Cell and Gene Therapy Development and Manufacturing – supported by the Cell and Gene Therapy Catapult.
TRACK CHAIRS: James Kusena (MicrofluidX Ltd) and Lee Dunham (CGT Catapult)
Abstract
The field of Cell and Gene Therapy (CGT) is at the forefront of modern medical breakthroughs, offering unprecedented opportunities to treat, and potentially cure, a variety of previously intractable diseases. However, the journey from conceptualisation to clinical implementation is fraught with challenges, particularly in the realms of development and manufacturing. This track will delve into the cutting-edge strategies and technological advancements that are driving progress in CGT.
Auditorium 4
Chemistry in Drug Discovery: Innovation, Collaboration and Inspiration – supported by RSC
TRACK CHAIRS: A. Ganesan (Uni of East Anglia), Martin Swarbrick (Ryvu Therapeutics) & Katie Lim (RSC)
Abstract
Chemistry remains a key underpinning discipline in bringing new therapeutics to the clinic, more and more supported by the application of new strategies and technologies. The Royal Society of Chemistry’s track aims to illustrate these state-of-the-art developments through several case studies. The track kicks off with Maria Duca (Côte d’Azur University) on nucleic acid based therapeutics, then Ola Engkvist (AstraZeneca) and Feng Ren (Insilico Medicine) will describe how AI is impacting their pipeline from hit discovery to the clinic. The final session showcases first-in-class candidates for two emerging oncology targets: DNA polymerase theta (POLθ) by Ana Rego (Artios Pharma) and Werner syndrome RecQ helicase (WRN) by Henrik Moebitz (Novartis).
TECH THEATRE
Robotics, Automation, Data and AI: Driving Innovations and Key Applications in Drug Discovery
TRACK CHAIRS: Patrick Courtney (SiLA), Burkhard Schaefer (Splashlake) & Lorna Suckling (GSK)
Abstract
From physical manipulation to data modelling, join us to discover how robotics and automation are enabling science across drug discovery. This session, co-organised with SiLA, will consider both new innovations and current applications of automation in the chemical and biological fields, and will highlight the impact of Artificial Intelligence in this space. Join us for a series of talks from subject-leading speakers and get involved in our interactive panel discussions
BREAKTHROUGH ZONE
How to found & grow your start up: what & who you need to know (Joint Session with The Royal Society)
Track Chairs: Tim Hammonds (TRH Consulting), John Elvin (Royal Society) & Del Trezise (Sartorius)
Abstract
So you have a great idea and want to see it fly – what next? In this interactive track, speakers and panellists will consider the opportunities and challenges of commercialising breakthrough science and discuss the myriad support systems to help you succeed. The morning session includes best practices in technology transfer, sources of government and other funding, and how the Royal Society supports new entrepreneurs across the UK. After lunch, views from seed-stage venture capital, accelerator program and professional business support network experts will be shared. The session will include plenty of time for questions and is targeted toward both new and experienced scientists that are keen to learn more about navigating the innovation support landscape.
REGISTER
WHAT CAN I EXPECT FROM DRUG DISCOVERY 2024?
Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling.
This year’s Scientific Content Partners are the Cell & Gene Therapy Catapult, the Royal Society of Chemistry, SBi2 and SLAS, all of whom are providing science tracks prepared by their community members. And in the middle of all this science there is the exhibition hall, which is a great opportunity to meet over two hundred drug discovery suppliers and to learn about all the latest products and services you can use in your research. Whether you’re involved in early drug discovery research or translating your promising therapy to the clinic, you’ll be sure to discover something that can help you at this year’s event.
ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and with a prayer room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events.
POSTER SUBMISSION AT ELRIG EVENTS
We are no longer accepting posters for this event.
If you have submitted a poster for review, you will be emailed if it has been accepted. You can also view all accepted posters below.
During the event:
A board will be available with your poster number and Velcro strips to affix your poster (your poster must be A0 portrait).
Poster sessions will take place for 30-minute in the networking session from 17:00 at the end of Day 1 and for 30 mins during the lunchbreak at 13:00 on Day 2. You will be expended to be at your poster during these times to answer questions from delegates.
A Poster Prize will be awarded for Best Early Career Professional Poster, the posters will be judged (you will not need to be at your poster during judging) and the prize awarded during the opening session on day 2 of the event. (Thurs 3 Oct)
During registration you will be asked if you identify as an ECP – An Early Career Professional (ECP) can be a student in higher education undertaking an undergraduate or postgraduate degree (including PhD), or within 5 years of finishing higher education and starting their career in life sciences and drug discovery. These ECPs are critical contributors to ELRIG, bringing new science, fresh ideas and energy to every event.
The prize is a glass trophy and £250, which can be accepted, donated to your lab or donated to a charity of your choice.
All posters will need to be collected at the end of the event and removed from site; any posters left at the end of the event will be disposed of.
Flash Poster presentations:
This is an opportunity to showcase your poster in a Flash presentation to the ELRIG community, if your poster is chosen you will need to prepare a 1 slide PowerPoint presentation to last no more than 3 minutes. The scientific judging panel will review the posters submitted for Flash poster presentations and if successful you will receive confirmation from the ELRIG Team two weeks prior to the event.
AWARDS
Kirsty Smitten Award
This award will recognise impact achieved by an Early Career Professional within the Life Science community. This award (formerly the ECP Impact Award) is named in honour of Kirsty Smitten, who’s pioneering work on antimicrobial compounds won her many accolades and awards, including the ECP Impact Award in 2021. Kirsty co-founded MetalloBio in Sheffield with a passion to combat antimicrobial resistance. Kirsty sadly died of a rare form of heart cancer in October 2023. She was a strong proponent of self-improvement, and was keen to inspire others to seize opportunities for personal growth.
Early Career Professional applicants can demonstrate impact through the following ways:
- Through the delivery of impactful science, contributing to early, pre-clinical drug discovery
- By their science or technology development work
- Through their leadership or facilitation of collaborations within the drug-discovery space
- Through other philanthropic and volunteering contributions
Winners will present their work as a standalone talk at ELRIG’s flagship Drug Discovery 2024 conference, and will receive £500 to be used for their personal development.
To be eligible, the recipient must be an Early Career Professional (ECP) – they can be a student in higher education undertaking an undergraduate or postgraduate degree (including PhD), or within 5 years of finishing higher education and starting their career in life sciences and drug discovery. These ECPs are critical contributors to ELRIG, bringing new science, fresh ideas and energy to every event.
To apply, ECPs may apply directly or be nominated by a colleague, as ELRIG invites the wider community to propose ECP colleagues that have made noteworthy impact. In each case, application requires submission of the following:
1-page, 300-word synopsis of the ECPs contribution and impact on early drug discovery, using the application form below and send a brief 2-page resume to sanj.kumar@elrig.org.
Forms need to be submitted by the closing deadline – Monday 2nd September 2024. The winner will be notified before the event.
INNOVATION AWARD
Applications open to all confirmed participants of the Breakthrough Zone at Drug Discovery 2o24
Once you have completed your application and payment for registration to join the ELRIG Breakthrough Zone, you are eligible to apply for the ELRIG Innovation Award. Please email Sarah.lupton@elrig.org for more information on how to apply.
AWARD PRIZE INCLUDES:
- Opportunity to give a 10-minute pitch following keynote presentation at Drug Discovery 2024, reaching over 1000 delegates
- Your registration fee refunded
- Access to ELRIG media partners to share news of your award win and innovation.
DETAILS TO NOTE
The deadline to apply for the ELRIG Innovation Award is 13th September, registration for the Breakthrough Zone must be completed prior to this date.
The ELRIG Innovation Award winner will be notified by 23d September, in order to give time to prepare the 10-minute pitch to be shared at the conference. (2-3 October 2024 at ExCeL London)
Any questions please email sarah.lupton@elrig.org
ECP POSTER AWARD
A Poster Prize will be awarded for Best Early Career Professional Poster. Find out more about how to submit your poster
The posters will be judged during Drug Discovery 2024 (you will not need to be at your poster during judging) and the prize awarded during the opening session on day 2 of the event. (Thurs 3 Oct)
POSTER DEADLINES
To be considered for an oral flash poster presentation in the Exhibition space please have your title & abstract submitted by 2nd September. The deadline for all posters for general display abstract & title 15th September.
POSTER ACCEPTANCE
The author will be held responsible for false statements, the scientific judging panel will ensure the poster is relevant to the event content. Successful poster applications will be notified via email and the poster display number will be given approximately two weeks before the event.
During the event
A board will be available with your poster number and Velcro strips to affix your poster (your poster must be A0 portrait).
Poster sessions will take place for 30-minute in the networking session at the end of Day 1 and for 30 mins during the lunchbreak on Day 2. You will be expended to be at your poster during these times to answer questions from delegates.
A Poster Prize will be awarded for Best Early Career Professional Poster, the posters will be judged (you will not need to be at your poster during judging) and the prize awarded during the opening session on day 2 of the event. (Thurs 3 Oct)
During registration you will be asked if you identify as an ECP – An Early Career Professional (ECP) can be a student in higher education undertaking an undergraduate or postgraduate degree (including PhD), or within 5 years of finishing higher education and starting their career in life sciences and drug discovery.
These ECPs are critical contributors to ELRIG, bringing new science, fresh ideas and energy to every event.
The prize is a glass trophy and £250, which can be accepted, donated to your lab or donated to a charity of your choice.
All posters will need to be collected at the end of the event and removed from site; any posters left at the end of the event will be disposed of.
Breakthrough Zone
We are no longer taking applications for the Breakthrough Zone as it is fully booked.
What is ELRIG’s Breakthrough Zone?
A dedicated area in the Exhibition Hall for start up companies and entrepreneurs to showcase their science and innovation.
Why should my company exhibit in the Breakthrough Zone?
Drug Discovery 2024 is the leading life science conference in Europe focussed on drug discovery, with over 2000 pharma, biotech and academic delegates and 180 companies exhibiting. Your early adopters, target customers and collaborators will definitely be there!
What do I get as an Exhibitor in the Breakthrough Zone?
An A0 poster space with tabletop
5 minute flash presentation in Breakthrough Zone Theatre
Opportunity to win ELRIGs coveted Innovation Award – 10 minute presentation on the main stage & your fee refunded
Blinded GDPR-compliant delegate list
Access to the Exhibitor features in the Event App including lead capture
What does it cost?
£500 + VAT
Are there any conditions to apply?
To be eligible to participate in the Breakthrough Zone and enter the ELRIG Innovation Award competition, your company should have less than 25 full-time employees and/or have a turnover of less than £2.5M.
APPLY FOR THE ELRIG INNOVATION AWARD
Once you have completed your application and payment for registration to join the ELRIG Breakthrough Zone, you are eligible to apply for the ELRIG Innovation Award. Please email Sarah.lupton@elrig.org for more information on how to apply.
Award Prize includes:
- Opportunity to give a 10-minute pitch following keynote presentation at Drug Discovery 2024, reaching over 1000 delegates
- Your registration fee refunded
- Access to ELRIG media partners to share news of your award win and innovation.
Details to note
The deadline to apply for the ELRIG Innovation Award is 13th September, registration for the Breakthrough Zone must be completed prior to this date.
The ELRIG Innovation Award winner will be notified by 23d September, in order to give time to prepare the 10-minute pitch to be shared at the conference. (2-3 October 2024 at ExCeL London)
Any questions please email sarah.lupton@elrig.org
What’s happening in the Breakthrough Zone?
Day 1: Wed 2nd October
Track Chairs: Louise-Jane Affleck (Revvity) & Sarah Lupton (ELRIG)
Breakthrough Zone Company Showcase
The Breakthrough Zone (BZ) welcomes innovative start-up life science companies, each developing cutting edge technologies and platforms to drive drug discovery. In this track BZ companies will showcase their ground-breaking science and impact areas in a quick-fire 3-slide, 5-minute presentation format. The goal of the session is to introduce attendees to the most exciting developments in the field and connect them to new users, collaborators and entrepreneurs.
Day 2: Thurs 3rd October
Track Chairs: Tim Hammonds (TRH Consulting), John Elvin (Royal Society) & Del Trezise (Sartorius)
How to found & grow your start up: what & who you need to know (Joint Session with The Royal Society)
Abstract: So you have a great idea and want to see it fly – what next? In this interactive track, speakers and panellists will consider the opportunities and challenges of commercialising breakthrough science and discuss the myriad support systems to help you succeed. The morning session includes best practices in technology transfer, sources of government and other funding, and how the Royal Society supports new entrepreneurs across the UK. After lunch, views from seed-stage venture capital, accelerator program and professional business support network experts will be shared. The session will include plenty of time for questions and is targeted toward both new and experienced scientists that are keen to learn more about navigating the innovation support landscape.
View the event floor plan and find exhibitors here
Social Media
Download our useful social media images to share that you’ll be attending Drug Discovery 2024 with your network.
VENDOR GRAPHICS
DELEGATE GRAPHICS
SPEAKER GRAPHICS
SPEAKERS
KEYNOTES
Ijeoma Uchegbu
Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience at UCL, a fellow of the Academy of Medical Sciences, an honorary fellow of the Royal Society of Chemistry, a governor on the Wellcome board and Co-Founder and CSO of Nanomerics. She will also take up the position of President of Wolfson College, University of Cambridge later this year. Prof Uchegbu has served as Chair of the Academy of Pharmaceutical Sciences, Scientific Secretary of the Controlled Release Society and UCL Provost’s Envoy for Race Equality. Her pioneering work on the mechanisms of drug transport led to the discovery of transformational peptide nanoparticles that can be delivered across the blood–brain barrier, namely enkephalin pain medicine candidate, Envelta™. She has been awarded various prizes for her work and is listed in Bloomsbury Publishing’s Who’s Who 2024. Prof Uchegbu will showcase how nanoparticles can be used to enhance efficacy and minimise off-targets effects during her talk on the first day.
Marcus Schindler
Marcus Schindler was appointed Executive Vice President for Research and Early Development and CSO at Novo Nordisk in 2021. Prior to joining the company in 2018 as Senior Vice President for External Innovation and Strategy and later Senior Vice President for Global Drug Discovery, Prof Schindler was Vice President, Head of Cardiovascular and Metabolic Diseases Innovative Medicines
at AstraZeneca and Head of Research at (OSI) Prosidion. He also worked in various leadership roles at Boehringer Ingelheim, after having started his career with Glaxo Wellcome/GSK. Prof Schindler holds a PhD from the University of Cambridge and is Adjunct Professor of Pharmacology at the University of Gothenburg. His keynote presentation will focus on therapeutic approaches for metabolic disorders, such as obesity and diabetes.
ACCOMMODATION
Book your accommodation with ELRIG’s Registration & Accommodation Partner MICE Concierge Ltd
The event room blocks represent your best value and most local hotels for the event. We understand there is a wide choice of options so if you don’t want to use the event room blocks we have partnered with Booking.com to give you access to the widest choice of hotels. Compare prices and see the widest choice with
ELRIG is only able to provide suggestions on how delegates may travel to or places they may stay at, to attend its events. However, ELRIG cannot recommend nor endorse any of the travel choices nor hotels that attendees make and is not liable for any of the services that its delegates procure.
FUND A BUS – Applications are now closed.
At ELRIG, we believe that accessibility is key to advancing science, which is why our events are always free-to-attend. Now, we’re taking it a step further with our brand-new “Fund a Bus” initiative, ensuring that you and your colleagues can easily join us at Drug Discovery 2024 taking place on 2-3 October at ExCeL, London
What’s “Fund a Bus”?
We understand that travel can be a barrier, so we’re offering to cover the cost of a minibus to bring your university department or research institute to the event. This is open to any life science or drug discovery-focused groups located anywhere in the UK (outside the M25). You’ll be able to arrive before 9 AM and depart after 5 PM, attending day 1, day 2 or both days, with lunch, tea/coffee, and networking drinks on us!
What You Need to Know
Deadline – Complete your application form by Friday, 30th August to apply.
Group Size – Buses can accommodate groups of 10 to 30 people
What’s Covered -Travel to and from the event, as well as lunch and refreshments during the conference.
What’s Not Covered – Accommodation, breakfast, and evening meals.
Registration for Drug Discovery 2024 is free!
Applications are now closed for Drug Discovery 2024, but get in touch about similar opportunities in 2025. Email info@elrig.org
FLOORPLAN DRUG DISCOVERY 2024
DELEGATE FREQUENTLY ASKED QUESTIONS
Are ELRIG events really FREE to attend? Yes ELRIG events are FREE to attend.
We are a Not-for-Profit organisation and put on these events to help our industry grow and prosper. Our organisation is made up of volunteers, and a small team of part-time staff.
We cover the cost of each event from sponsorship and stand sales. If you come to one of our conferences, please take time visit the exhibition and speak to our vendors.
How do I register to attend Drug Discovery 2024? Register here
How do I change / cancel my registration? When you first made your registration, you were asked to create a password : this password + your e-mail address will allow you to re-enter the system at any time, and update or cancel your registration.
If you cannot remember your password, follow the link to reset your password on the registration page
Delegates : What do I need to bring with me? Please save your ticket to your smart device or print a copy. Upon arrival at the venue visit the ELRIG registration and scan the QR Code. Your badge will be automatically printed. If you forget or lose your QR Code you can enter your email address to print your badge.
Can I register on arrival? Yes you can. We would prefer that register before the event but if you have not, you can register at the ELRIG registration desk.
How do I cancel my registration if I cannot come? A link for cancellations will be available soon, please check back
We have several sponsorship opportunities available to our vendors that can provide a wide range of new and exciting benefits for your organisation. We are also happy to discuss a tailored package to suit your budget. Contact us on info@elrig.org
INDUSTRY PARTNERS
PRESS RELEASES – Drug Discovery 2024
Welcome to the partner news & press releases hub for Drug Discovery 2024. This is a dedicated space where our conference partners—whether you’re a vendor, speaker, or delegate—can share your latest news, updates, and press releases.
Have something exciting to announce? We’d love to help you spread the word. To add your press release to this page, simply email us at info@elrig.org.
Stay informed and keep the conversation going!
SCIENTIFIC CONTENT PARTNERS
INDUSTRY PARTNERS
Drug Discovery 2023 highlights
Interested in becoming an
Exhibitor or Sponsor?
Although all ELRIG events are free of charge, we rely on our
valued exhibitors and sponsors to help fund our future events.